SARAH ROBINSON: Open Payments
NPI 1821639402 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 69 payments from 18 companies in 2025. Trend: 2023 $1,387 · 2024 $1,921 · 2025 $1,522
Food & beverage: $1,513Education: $9
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $212 |
| Novo Nordisk Inc | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 11 | $179 |
| E.R. Squibb & Sons, L.L.C. | 3 | $166 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $133 |
| PFIZER INC. | 6 | $116 |
| SCPHARMACEUTICALS INC. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| BridgeBio Pharma, Inc. | 3 | $48 |
Products named: REPATHA, WAINUA, Ozempic, LifeVest, FUROSCIX, VYNDAQEL, LEQVIO, VERQUVO.
Industry payments across DE — which companies pay providers there.
